A tragic paradox, Gilead updates, and many Pfizer information
That is the net model of STAT’s particular e-newsletter from the annual assembly of the American Society of Oncology. For extra updates on the most recent in most cancers information, join our Most cancers Briefing e-newsletter right here.
ASCO is often sweltering, nevertheless it’s surprisingly chilly in the present day. We’re again with a roundup of tragic paradoxes, a race for brand spanking new breast most cancers medicine, and all that jazz.
First, although, we wish to thank everybody who turned out for our STAT@ASCO occasion final evening. It was a packed home, and a terrific crowd. A reminder: Our digital STAT Recap occasion in regards to the convention might be Wednesday, and it’s not too late to enroll.
This text is unique to STAT+ subscribers
Unlock this text — plus day by day protection and evaluation of the biotech sector — by subscribing to STAT+.
Have already got an account? Log in
To learn the remainder of this story subscribe to STAT+.
